Roberto I Troisi1, Giammauro Berardi2, Federico Tomassini2, Mauricio Sainz-Barriga3. 1. Deparment of General, Hepatobiliary and Liver Transplantation Surgery, UZ Ghent, Ghent, Belgium. Electronic address: roberto.troisi@ugent.be. 2. Deparment of General, Hepatobiliary and Liver Transplantation Surgery, UZ Ghent, Ghent, Belgium. 3. Department of Abdominal Organ Transplantation, Louvain University Hospitals.
Abstract
INTRODUCTION: Small-for-size syndrome (SFSS) has an incidence between 0 and 43% in small-for-size graft (SFSG) adult living donor liver transplantation (LDLT). Portal hypertension following reperfusion and the hyperdynamic splanchnic state are reported as the major triggering factors of SFSS. Intra- and postoperative strategies to prevent or to reduce its onset are still under debate. We analyzed graft inflow modulation (GIM) during adult LDLT considering the indications, efficacy of the available techniques, changes in hemodynamics and outcomes. MATERIALS AND METHODS: A systematic literature search was performed using PubMed, EMBASE, Scopus and the Cochrane Library Central. Treatment outcomes including in-hospital mortality and morbidity, re-transplantation rate, 1-, 3-, and 5-year patient overall survival and 1-, 3-, and 5-year graft survival rates, hepatic artery and portal vein flows and pressures before and after inflow modulation were analyzed. RESULTS: From 563 articles, 12 studies dated between 2003 and 2014 fulfilled the selection criteria and were therefore included in the study. These comprised a total of 449 adult patients who underwent inflow modulation during adult-to-adult LDLT. Types of GIM described were splenic artery ligation, splenectomy, meso-caval shunt, spleno-renal shunt, portocaval shunt, and splenic artery embolization. Mortality and morbidity ranged between 0 and 33% and 17% and 70%, respectively. Re-transplantation rates ranged between 0% and 25%. GIM was associated with good survival for both graft and recipients, reaching an 84% actuarial rate at 5 years. Through the use of GIM, irrespective of the technique, a statistically significant reduction of PVF and PVP was obtained. CONCLUSIONS: GIM is a safe and efficient technique to avoid or limit portal hyperperfusion, especially in cases of SFSG, decreasing overall morbidity and improving outcomes.
INTRODUCTION: Small-for-size syndrome (SFSS) has an incidence between 0 and 43% in small-for-size graft (SFSG) adult living donor liver transplantation (LDLT). Portal hypertension following reperfusion and the hyperdynamic splanchnic state are reported as the major triggering factors of SFSS. Intra- and postoperative strategies to prevent or to reduce its onset are still under debate. We analyzed graft inflow modulation (GIM) during adult LDLT considering the indications, efficacy of the available techniques, changes in hemodynamics and outcomes. MATERIALS AND METHODS: A systematic literature search was performed using PubMed, EMBASE, Scopus and the Cochrane Library Central. Treatment outcomes including in-hospital mortality and morbidity, re-transplantation rate, 1-, 3-, and 5-year patient overall survival and 1-, 3-, and 5-year graft survival rates, hepatic artery and portal vein flows and pressures before and after inflow modulation were analyzed. RESULTS: From 563 articles, 12 studies dated between 2003 and 2014 fulfilled the selection criteria and were therefore included in the study. These comprised a total of 449 adult patients who underwent inflow modulation during adult-to-adult LDLT. Types of GIM described were splenic artery ligation, splenectomy, meso-caval shunt, spleno-renal shunt, portocaval shunt, and splenic artery embolization. Mortality and morbidity ranged between 0 and 33% and 17% and 70%, respectively. Re-transplantation rates ranged between 0% and 25%. GIM was associated with good survival for both graft and recipients, reaching an 84% actuarial rate at 5 years. Through the use of GIM, irrespective of the technique, a statistically significant reduction of PVF and PVP was obtained. CONCLUSIONS: GIM is a safe and efficient technique to avoid or limit portal hyperperfusion, especially in cases of SFSG, decreasing overall morbidity and improving outcomes.
Authors: Matthew Brovold; Joana I Almeida; Iris Pla-Palacín; Pilar Sainz-Arnal; Natalia Sánchez-Romero; Jesus J Rivas; Helen Almeida; Pablo Royo Dachary; Trinidad Serrano-Aulló; Shay Soker; Pedro M Baptista Journal: Adv Exp Med Biol Date: 2018 Impact factor: 2.622
Authors: Mohammad Golriz; Anastasia Lemekhova; Elias Khajeh; Omid Ghamarnejad; Mohammed Al-Saeedi; Oliver Strobel; Thilo Hackert; Beat Müller-Stich; Martin Schneider; Christoph Berchtold; Parham Tinoush; Philipp Mayer; De-Hua Chang; Karl Heinz Weiss; Katrin Hoffmann; Arianeb Mehrabi Journal: BMJ Open Date: 2019-10-11 Impact factor: 2.692
Authors: Ka Wing Ma; Kelly Hiu Ching Wong; Albert Chi Yan Chan; Tan To Cheung; Wing Chiu Dai; James Yan Yue Fung; Wong Hoi She; Chung Mau Lo; Kenneth Siu Ho Chok Journal: World J Gastroenterol Date: 2019-09-28 Impact factor: 5.742